197 related articles for article (PubMed ID: 9074562)
1. Avoiding fluoroquinolone resistance. Strategies for primary care practice.
Stratton CW
Postgrad Med; 1997 Mar; 101(3):247-50, 255. PubMed ID: 9074562
[TBL] [Abstract][Full Text] [Related]
2. Quinolone antimicrobial agents.
Neu HC
Annu Rev Med; 1992; 43():465-86. PubMed ID: 1580602
[TBL] [Abstract][Full Text] [Related]
3. Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals.
Rogues AM; Dumartin C; Amadéo B; Venier AG; Marty N; Parneix P; Gachie JP
Infect Control Hosp Epidemiol; 2007 Dec; 28(12):1389-95. PubMed ID: 17994520
[TBL] [Abstract][Full Text] [Related]
4. Microbial drug resistance and the roles of the new antibiotics.
Longworth DL
Cleve Clin J Med; 2001 Jun; 68(6):496-7, 501-2, 504. PubMed ID: 11405611
[TBL] [Abstract][Full Text] [Related]
5. Potential role of fluoroquinolones in pediatric infections.
Douidar SM; Snodgrass WR
Rev Infect Dis; 1989; 11(6):878-89. PubMed ID: 2513628
[TBL] [Abstract][Full Text] [Related]
6. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.
Willcox MD
Clin Exp Optom; 2011 Mar; 94(2):161-8. PubMed ID: 21083760
[TBL] [Abstract][Full Text] [Related]
7. High-dose intravenous fluoroquinolones in the treatment of severe infections.
Modai J
J Chemother; 1999 Dec; 11(6):478-85. PubMed ID: 10678789
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of antibiotic and antimicrobial biocide susceptibility data in clinical isolates of methicillin-sensitive Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa between 1989 and 2000.
Lambert RJ
J Appl Microbiol; 2004; 97(4):699-711. PubMed ID: 15357719
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
[TBL] [Abstract][Full Text] [Related]
10. Use of fluoroquinolones: practical considerations.
Ponte CD; Fisher MA
Am Fam Physician; 1993 Apr; 47(5):1243-9. PubMed ID: 8465719
[TBL] [Abstract][Full Text] [Related]
11. Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureus.
Bosso JA; Mauldin PD
Antimicrob Agents Chemother; 2006 Jun; 50(6):2106-12. PubMed ID: 16723572
[TBL] [Abstract][Full Text] [Related]
12. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics].
Miyazakin S; Yamaguchi K
Rinsho Byori; 1997 Jul; Suppl 105():162-73. PubMed ID: 9379536
[No Abstract] [Full Text] [Related]
13. Epidemiology of quinolone resistance: Europe and North and South America.
Goldstein FW; Acar JF
Drugs; 1995; 49 Suppl 2():36-42. PubMed ID: 8549361
[TBL] [Abstract][Full Text] [Related]
14. [Which partner for the betalactam agent in empiric combined therapy? I Fluoroquinolone].
Bedos JP
Ann Fr Anesth Reanim; 2004 Jun; 23(6):636-8. PubMed ID: 15234734
[No Abstract] [Full Text] [Related]
15. Management of fluoroquinolone use to avoid microbial resistance in clinical practice.
Peterson LR
Postgrad Med; 2001 Feb; 109(2 Suppl):51-9. PubMed ID: 19667558
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus.
Maggiolo F; Capra R; Bottura P; Pravettoni G; Migliorino M; Suter F
J Chemother; 2000 Jun; 12(3):195-8. PubMed ID: 10877512
[TBL] [Abstract][Full Text] [Related]
17. Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children.
Bonafede ME; Blumer JL
Adv Pediatr Infect Dis; 1996; 12():71-108. PubMed ID: 9033976
[No Abstract] [Full Text] [Related]
18. Fluoroquinolone antimicrobial agents.
Wolfson JS; Hooper DC
Clin Microbiol Rev; 1989 Oct; 2(4):378-424. PubMed ID: 2680058
[TBL] [Abstract][Full Text] [Related]
19. The clinical consequences of antimicrobial resistance.
Rice LB
Curr Opin Microbiol; 2009 Oct; 12(5):476-81. PubMed ID: 19716760
[TBL] [Abstract][Full Text] [Related]
20. [Fluoroquinolones, 10 years later].
de la Blanchardière A; Carbon C
Rev Prat; 1993 Sep; 43(14):1830-8. PubMed ID: 8310228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
